NHS Health Data Use Case Study Library

Global patterns in hip fractures: trends in occurrence, treatment, and survival - Amgen

Hip fractures relating to weak and brittle bones are a global public health concern, with over 10 million cases per year globally.

Assessing Covid-19 vaccine effectiveness and safety in England - AstraZeneca

Vaccines played an enormous role in reducing the impact of the COVID-19 pandemic, saving an estimated 100,000 lives in the UK.

Do type 2 diabetes medicine trial results reflect the UK patient population? - Eli Lilly

Cardiovascular disease (CVD) is a leading cause of death and illness among individuals with type 2 diabetes (T2D).

How well does the medicine, cabozantinib, work for kidney cancer patients who have already received treatment? - Ipsen

Kidney cancer is the 6th most common cancer in the UK, with over 10,000 new cases per year.

Building an online platform to test personalised patient information leaflets - Pfizer

More than one billion medicines are prescribed each year in the UK, but a large proportion of patients do not take their medication as instructed, which can lead to worse health outcomes.

Understanding the safety of the drug eliglustat over time for adults with Gaucher disease - Sanofi

Gaucher disease is a rare genetic condition where fatty substances build up in organs, like the liver, spleen and bones.

A thorough investigation of patient genetic data to improve treatments for specific conditions - UCB

Many causes of disease are associated with an individual’s genetic make-up and there is increasing interest in medical research to understand how our genes might influence our chances of getting a disease.

Investigating fungal infections in cancer patients receiving treatment in England - Pfizer

Cancer directly affects thousands of people in the UK, with over 457,000 new cases and nearly 180,000 deaths in 2020 alone.